Success Metrics

Clinical Success Rate
75.0%

Based on 9 completed trials

Completion Rate
75%(9/12)
Active Trials
0(0%)
Results Posted
56%(5 trials)
Terminated
3(18%)

Phase Distribution

Ph phase_1
1
6%
Ph phase_2
2
12%
Ph phase_4
5
29%
Ph not_applicable
1
6%
Ph phase_3
7
41%

Phase Distribution

1

Early Stage

2

Mid Stage

12

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
1(6.3%)
Phase 2Efficacy & side effects
2(12.5%)
Phase 3Large-scale testing
7(43.8%)
Phase 4Post-market surveillance
5(31.3%)
N/ANon-phased studies
1(6.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

9 of 12 finished

Non-Completion Rate

25.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

17

all time

Status Distribution
Active(2)
Completed(9)
Terminated(3)
Other(3)

Detailed Status

Completed9
unknown3
Terminated3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
17
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.3%)
Phase 22 (12.5%)
Phase 37 (43.8%)
Phase 45 (31.3%)
N/A1 (6.3%)

Trials by Status

unknown318%
completed953%
not_yet_recruiting212%
terminated318%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07110935Phase 1

Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.

Completed
NCT06556134Phase 4

Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients

Completed
NCT06427200Phase 4

Efficacy and Safety of Lactoferrin in Heart Failure Patients

Not Yet Recruiting
NCT05225545Phase 3

Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis

Unknown
NCT01155388Phase 3

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease

Terminated
NCT01155375Phase 3

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

Terminated
NCT05114278Phase 4

Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)

Not Yet Recruiting
NCT01414075Phase 2

Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

Completed
NCT00223938Phase 4

Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.

Terminated
NCT02979249Not Applicable

Oral Iron for Erythropoietic Protoporphyrias

Completed
NCT04464850Phase 3

Intravenous Versus Oral Iron Therapy in Hemodialysis Patients

Unknown
NCT01820052Phase 3

A Randomized Trial of Oral Iron Therapy in Fibromyalgia

Completed
NCT02300428

Health Economics of the Use of Ferrous Iron Salts in Primary Care in the UK.

Completed
NCT01857011Phase 3

Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty

Completed
NCT01787526Phase 3

Intravenous High Dose Iron in Blood Donors

Completed
NCT00223977Phase 2

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

Completed
NCT00199277Phase 4

Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.

Unknown

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17